Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
American Society of Nephrology

2. Address

Address1
1401 H Street, N.W.
 Address2
​Suite 900
City
WASHINGTON
 State
DC
 Zip Code
20005
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Ms.
​Rachel Meyer
​5057202009
​rmeyer@asn-online.org
5. Senate ID#
​80656-12
7. Client Name Self Check if client is a state or local government or instrumentality
​American Society of Nephrology
6. House ID#
​362850000
TYPE OF REPORT 8. Year
​2025
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​80,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Rachel N. Meyer
 Date
7/23/2025 1:27:28 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs
-Expanding Support for Living Donors Act (draft bill) Draft legislation to expand eligibility for living kidney donors to receive reimbursement for living kidney donation-related costs
-CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis
-Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations
-Removing Barriers for Organ Donation Act (bill number forthcoming) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination
-Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582) Clarifies and strengthens protections for Americans who donate an organ
-One Big, Beautiful Bill (H.R. 1) ASN raised concerns about access to care for people with kidney diseases, including kidney failure and transplants, as well as the effect of limits on federal loan programs for the future nephrology workforce
-Medicare Patient Access and Practice Stabilization Act of 2025 (H.R. 879) Legislation to reverse a recent cut to physicians and other health professionals in the Medicare program and to provide stability in Medicare physician payments moving forward
-$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs)
-$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)
-Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations
-Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health)
-Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS
-Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
David
White
​
​
Rachel
Meyer
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code SCI

16. Specific lobbying issues

-$51.303B in appropriations for NIH in FY26 (to support investments in basic, clinical, translational, and other health-related research activities)
-$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Ryan
Murray
​
Senior Manager of Policy and Government Affairs
Rachel
Meyer
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)